HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
In-San Kim Selected Research
In-San Kim Research Topics
Disease
112
Neoplasms (Cancer)
01/2022 - 10/2002
10
Neoplasm Metastasis (Metastasis)
01/2021 - 10/2002
10
Breast Neoplasms (Breast Cancer)
11/2020 - 05/2008
10
Lung Neoplasms (Lung Cancer)
01/2019 - 09/2003
8
Melanoma (Melanoma, Malignant)
10/2021 - 03/2006
6
Inflammation (Inflammations)
01/2020 - 10/2003
6
Atherosclerotic Plaque (Atheroma)
01/2020 - 06/2008
6
Atherosclerosis
01/2020 - 10/2008
4
Sepsis (Septicemia)
01/2020 - 04/2014
4
Carcinogenesis
10/2017 - 01/2007
4
Cadaver (Cadavers)
09/2009 - 04/2008
4
Fibrosis (Cirrhosis)
06/2008 - 10/2002
3
Thrombosis (Thrombus)
01/2018 - 06/2007
3
Urinary Bladder Neoplasms (Bladder Cancer)
10/2016 - 01/2007
3
Colonic Neoplasms (Colon Cancer)
02/2015 - 09/2008
3
Genetic Predisposition to Disease (Genetic Predisposition)
04/2008 - 10/2003
3
Squamous Cell Carcinoma (Epidermoid Carcinoma)
02/2008 - 10/2003
3
Hereditary Corneal Dystrophies
10/2007 - 03/2002
3
Adenocarcinoma
01/2007 - 10/2003
2
Colorectal Neoplasms (Colorectal Cancer)
10/2021 - 01/2021
2
Hypoxia (Hypoxemia)
01/2021 - 02/2003
2
Pancreatic Neoplasms (Pancreatic Cancer)
11/2020 - 01/2019
Drug/Important Bio-Agent (IBA)
39
Peptides (Polypeptides)
IBA
10/2021 - 03/2004
23
Pharmaceutical Preparations
IBA
10/2021 - 02/2008
23
Proteins (Proteins, Gene)
FDA Link
01/2021 - 03/2002
21
Doxorubicin (Adriamycin)
FDA Link
Generic
10/2021 - 08/2003
12
glycol-chitosan
IBA
02/2014 - 08/2003
10
Transforming Growth Factor beta (TGF-beta)
IBA
10/2010 - 03/2002
9
Biomarkers (Surrogate Marker)
IBA
10/2021 - 10/2003
9
Prodrugs
IBA
01/2021 - 02/2015
8
Ligands
IBA
10/2021 - 01/2008
7
Ferritins (Ferritin)
IBA
10/2021 - 03/2016
7
Integrins
IBA
07/2018 - 01/2008
6
Caspases
IBA
10/2021 - 12/2009
6
Coloring Agents (Dyes)
IBA
01/2019 - 02/2010
6
Small Interfering RNA (siRNA)
IBA
10/2017 - 02/2008
6
Drug Carriers
IBA
11/2011 - 09/2006
5
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
01/2022 - 10/2003
5
Therapeutic Uses
IBA
10/2021 - 02/2008
5
Caspase 3 (Caspase-3)
IBA
01/2019 - 02/2015
5
Interleukin-4 Receptors (Interleukin 4 Receptor)
IBA
03/2016 - 10/2008
5
Heparin (Liquaemin)
FDA Link
Generic
12/2008 - 09/2006
5
Transforming Growth Factor beta1 (TGF beta 1)
IBA
05/2007 - 10/2002
4
Cisplatin (Platino)
FDA Link
Generic
12/2021 - 04/2008
4
Immune Checkpoint Inhibitors
IBA
10/2021 - 01/2021
4
Antineoplastic Agents (Antineoplastics)
IBA
10/2021 - 05/2009
4
Cytokines
IBA
01/2021 - 07/2010
4
Poloxamer (Poloxamer 407)
IBA
01/2020 - 07/2015
4
Liposomes (Liposome)
IBA
01/2019 - 04/2011
4
Micelles
IBA
10/2017 - 11/2007
4
Polymers
IBA
10/2017 - 02/2007
4
Fibronectins (Fibronectin)
IBA
06/2016 - 03/2002
4
cysteinyl- glutaminyl- arginyl- prolyl- prolyl- arginine
IBA
01/2015 - 12/2010
4
Phosphatidylserines
IBA
01/2015 - 09/2008
4
Fluorescein (Funduscein)
FDA Link
Generic
11/2008 - 08/2003
3
Intercellular Signaling Peptides and Proteins (Growth Factors)
IBA
01/2022 - 08/2004
3
Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)
IBA
01/2022 - 03/2013
3
rho-Associated Kinases
IBA
11/2021 - 01/2018
3
liposomal doxorubicin (Doxil)
FDA Link
10/2021 - 04/2011
3
Membrane Proteins (Integral Membrane Proteins)
IBA
12/2020 - 04/2016
3
Enzymes
IBA
10/2020 - 11/2011
3
Antigens
IBA
11/2019 - 10/2003
3
Collagen
IBA
10/2018 - 10/2007
3
Disulfides
IBA
10/2017 - 07/2012
3
Deoxycholic Acid (Sodium Deoxycholate)
IBA
10/2017 - 02/2008
3
Tumor Biomarkers (Tumor Markers)
IBA
12/2016 - 01/2016
3
KLA peptide
IBA
10/2016 - 06/2008
3
Angiogenesis Inhibitors
IBA
04/2016 - 12/2008
3
Messenger RNA (mRNA)
IBA
07/2015 - 10/2002
3
Hyaluronic Acid (Hyaluronan)
IBA
01/2015 - 10/2003
3
Camptothecin
IBA
01/2015 - 05/2008
3
Paclitaxel (Taxol)
FDA Link
Generic
05/2014 - 03/2006
3
Histones (Histone)
IBA
01/2014 - 12/2010
3
Extracellular Matrix Proteins
IBA
02/2012 - 03/2002
3
2- cyclohexylidenhydrazo- 4- phenyl- thiazole
IBA
11/2011 - 05/2008
3
Fluorescein-5-isothiocyanate (FITC)
IBA
10/2011 - 08/2003
3
Radioisotopes (Radionuclides)
IBA
12/2010 - 02/2007
3
Chitosan
IBA
09/2010 - 08/2003
3
monomethoxypolyethylene glycol (MPEG)
IBA
06/2010 - 11/2007
3
poly(beta-amino ester)
IBA
06/2010 - 11/2007
3
Guanosine Diphosphate (GDP)
IBA
01/2010 - 10/2003
3
Cell Adhesion Molecules
IBA
04/2008 - 03/2002
3
Desoxycorticosterone Acetate (DOCA)
FDA Link
06/2007 - 09/2006
3
Glucose (Dextrose)
FDA Link
Generic
02/2007 - 03/2003
2
Acids
IBA
01/2022 - 11/2015
2
Biocompatible Materials (Biomaterials)
IBA
01/2022 - 08/2011
2
Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)
IBA
12/2021 - 01/2021
2
microplasmin
IBA
10/2021 - 01/2018
2
Apoptosis Regulatory Proteins
IBA
10/2021 - 10/2017
2
Hemostatics (Antihemorrhagics)
IBA
10/2021 - 01/2018
2
Cathepsin B
IBA
01/2021 - 02/2014
2
Anticoagulants
IBA
01/2021 - 03/2013
2
Fluorescent Dyes (Fluorescent Probes)
IBA
01/2020 - 12/2010
2
Protein C
IBA
01/2020 - 11/2015
Therapy/Procedure
49
Therapeutics
12/2021 - 10/2003
16
Immunotherapy
12/2021 - 09/2012
13
Drug Therapy (Chemotherapy)
01/2019 - 02/2007
4
Intravenous Injections
10/2020 - 02/2007
4
Intravenous Administration
01/2020 - 01/2006
4
Radiotherapy
01/2019 - 08/2015